To confirm whether CypA facilitates NSCLC chemoresistance through ferroptosis, CCK8 assays showed that CypA knockdown significantly suppressed the proliferation of drug‐resistant cells treated with RSL3 (Figure 7B; Figure S6B, Supporting Information). The gene discussed is PPIA; the disease is non-small cell lung carcinoma.